What You Should Know Preventive medical technology pioneer Neko Health has finalized a $700M Series C funding round led by Lightspeed Venture Partners and co-led by O.G. Venture Partners. The explosive pre-empted round values the Swedish-born company at nearly $7 billion—marking a staggering fourfold valuation leap from its $1.7 billion Series B milestone in January…
Listen to the article 8 min This audio is auto-generated. Please let us know if you have feedback. The $21 billion acquisition of Exact Sciences marked Abbott’s entry into cancer diagnostics, where a growing focus on blood-based screening tests holds promise for earlier detection and more targeted, personalized treatment. Progress continues to evolve, with research…
In a new study published in Science Translational Medicine on Wednesday, researchers say they have uncovered how Epstein-Barr virus launches immune responses that lead to the inflammation and nervous system damage seen in people with multiple sclerosis. “It’s very nice now to be able to understand more about the underlying mechanisms of how EBV likely…
Listen to the article 5 min This audio is auto-generated. Please let us know if you have feedback. Physicians billing Medicare would see a pay dip next year as part of a sweeping reimbursement rule that also aims to increase provider participation in accountable care organizations and overhaul quality reporting. Under the proposed regulation released…
Caroline Garry, Managing Director of Brand at Langrand Healthcare didn’t build a digital front door. It built a digital facade. Over the last decade, health systems invested heavily in the look and feel of modern consumer technology—clean interfaces, frictionless scheduling flows, real-time messaging features, instant cost estimate tools. They borrowed the visual language of companies…
Dive Brief: HistoSonics said Monday it received a CE mark for its Edison Histotripsy System, clearing the company to sell the cancer treatment in Europe. The Edison system delivers pulsed sound waves to destroy tumors. HistoSonics received de novo authorization in 2023 to sell the device in the U.S. for the treatment of liver cancer….
Ed’s stories explore prescription drug pricing, affordability and access, as well issues surrounding patents, litigation, and legislation. He is also the author of the morning Pharmalittle newsletter and the afternoon Pharmalot newsletter. Prescription medicines purchased in the U.S. under a controversial government discount program amounted to $100 billion in 2025, a 22.8% increase from the…
Dive Brief: HCA Healthcare slashed its 2026 earnings guidance after the growing amount of uninsured Americans — mostly as a result of turbulence on the Affordable Care Act exchanges — ate into the for-profit hospital giant’s income in the second quarter. HCA now expects net income between $6.3 billion and $6.7 billion this year, compared…
Reed Hanoun, Founder & CEO at NERON AI The senior living operator runs brain health programming for hundreds of residents and still can’t say, with confidence, which ones are genuinely improving. The rehabilitation provider clears a patient to return to activity based on symptoms, not on whether the underlying deficit is actually resolved. The sports…
Dive Brief: Medtronic is removing from the market certain lots of a catheter used to place pulmonary valves, the Food and Drug Administration said in a Monday recall notice. The affected devices have an increased risk that the distal tip may detach from the delivery catheter system, requiring another procedure to remove the tip. As…